Endo names leadership team appointments

Endo International has appointed Patrick Barry as U.S. Branded Pharmaceuticals’ new senior vice president and Matthew Davis as the new senior vice president of research and development at Branded.
Barry will begin serving in his new position effective immediately. Davis will be appointed to his new position on Jan. 3.
"We are excited to have Patrick and Matthew join Endo and I look forward to working closely with them," Endo President and CEO Paul Campanelli said. "They bring to Endo significant experience and demonstrated track records of success in their respective areas of expertise. Importantly, both are proven leaders and have built and inspired strong teams that have consistently exceeded performance expectations. We look forward to their success at Endo."
Before his new position with Endo, Barry was employed at Sanofi for more than 20 years. During his time there, he held multiple roles of increasing responsibility which included working in Sales Leadership, Marketing and Launch Planning.
Davis has served as chief medical officer at Lupin Pharmaceuticals and URL Pharma, which led to five NDA approvals and 21 U.S. patents received. He has broad knowledge in drug and device development and lifecycle management.